PRESS RELEASE
News
-
-
PRESS RELEASE
Bouygues : résultats des neuf premiers mois 2025
-
-
-
REGULATED PRESS RELEASE
Oxford Nanopore et bioMérieux lancent AmPORE-TB, une solution de séquençage, à usage de recherche uniquement, pour identifier rapidement la tuberculose résistante aux antibiotiques
Oxford Nanopore et bioMérieux lancent AmPORE-TB, une solution de séquençage pour identifier la tuberculose résistante aux antibiotiques, recommandée par l'OMS -
REGULATED PRESS RELEASE
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only solution for rapid characterization of drug resistant-tuberculosis, using nanopore sequencing technology -
-
-
-
PRESS RELEASE
Klöckner & Co doubles operating income before material special effects in third quarter of 2025 and continues positive trend
Klöckner & Co SE doubles operating income before special effects, reports €43 million EBITDA in Q3 2025. Sales slightly down but positive trend continues. Focus on higher value-added business and service centers
